MO BIO Laboratories, Inc. becomes ISO 9001:2008 certified
December 5, 2013
CARLSBAD, Calif. -- MO BIO Laboratories, Inc., the leader in soil, microbial, stool, and plant nucleic acid purification, has been independently audited and is now ISO 9001:2008 certified for the design and manufacture of reagents and kits for extraction, purification and analysis of samples for the life science research community, along with providing 3rd party [...]
Promega Introduces QuantiFluor ONE dsDNA System for Sensitive “Add-and-Read” DNA Quantitation
December 5, 2013
Madison, WI USA. - Promega Corporation announced today the launch of the QuantiFluor® ONE dsDNA System, a sensitive, dsDNA-specific fluorescent dye suitable for use in both research and clinical workflows. The new dye system is integrated into the new Promega Quantus™ Fluorometer and GloMax® detection instruments, but is compatible with any fluorometer capable of measuring [...]
Datacolor Continues International Growth by Founding a New Sales and Service Company in Brazil
December 4, 2013
Lawrenceville, NJ – Datacolor® (www.datacolor.com), a global leader in color management solutions, today announced the opening of its newest legal entity in São Paulo, Brazil. With the creation of its São Paulo based company, Datacolor is better equipped to participate in the country’s growing market for color management solutions in industries such as textile and [...]
December 4, 2013
Strand Life Sciences Private Limited, a global life sciences company headquartered in Bangalore, is collaborating with the San Francisco Bay Area based El Camino Hospital to locate a Strand Center for Genomics and Personalized Medicine at the Genomic Medicine Institute of the El Camino Hospital to accelerate the adoption of next generation sequencing based research [...]
December 4, 2013
Cambridge, UK: TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, is pleased to announce its Fill-It™, automated benchtop vial filling system is being routinely used at an innovative cell therapy company developing novel cancer immunotherapies, to improve processing speed and throughput of large batches of cells in [...]
Roche receives FDA clearance to use additional specimen types for chlamydia and gonorrhea test
December 4, 2013
PLEASANTON, Calif. -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of four additional specimen types with the cobas® CT/NG v2.0 Test to help physicians diagnose Chlamydia trachomatis (CT) and Neisseria Gonorrhoeae (NG) infections in symptomatic and asymptomatic [...]
December 4, 2013
OAKLAND, Calif. & SALT LAKE CITY -- Omicia, Inc., has announced a partnership with the University of Utah’s Utah Genome Project. Under a two-year licensing agreement with Omicia, the University will use and advance Opal, the company’s whole genome analysis platform for research and clinical applications. The agreement enables the University’s researchers and clinicians to [...]
LabCentral Signs New Agreement in Support of Life-Sciences Startups
December 4, 2013
CAMBRIDGE, Mass.-- LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences startups, announced that Life Technologies will provide an innovative technology suite of instruments representing the latest platforms developed by the company under an agreement inked last month. Life Technologies will also provide training and service support to LabCentral-based startups conducting genetic [...]
December 4, 2013
SEATTLE, WAS., and MADISON, WIS. – The Jain Foundation, a non-profit organization whose mission is to cure muscular dystrophies caused by dysferlin protein deficiency, today announced the signing of a Master Service Agreement with Cellular Dynamics International (CDI; Nasdaq: ICEL). CDI will create five induced pluripotent stem cell (iPSC) lines from patients with these dystrophies. [...]
ANSYS And Reaction Design Announce Signing Of Definitive Merger Agreement
December 4, 2013
PITTSBURGH and SAN DIEGO -- ANSYS (NASDAQ: ANSS), a global leader and innovator of engineering simulation software, announced today that it has entered into a definitive merger agreement with Reaction Design, a leading developer of chemistry simulation software. The transaction is expected to close in January 2014. Management will provide further details regarding the transaction [...]

